A randomised trial to compare dolutegravir plus boosted darunavir versus recommended standard of care antiretroviral regimens in people with HIV-1, whose first-line non … - DARA

A randomised trial to compare dolutegravir plus boosted darunavir versus recommended standard of care antiretroviral regimens in people with HIV-1, whose first-line non …

Author: PP Nyein, M Borok, N Eriobu, R Kaplan, N Kumarasamy

Informations

PublisherClinical Infectious Diseases, ciaf346, 2025

Publication Year2025

Source TypeGoogle Scholar

Citations

Google Scholar: 1

Documents & Links